Searchable abstracts of presentations at key conferences in endocrinology

ea0011p258 | Diabetes, metabolism and cardiovascular | ECE2006

Improvement of nutritional status in non-dialysed uremic diabetic patients

Raffaitin C , Chauveau P , Lasseur C , Barthe N , Gin H , Combe C , Corcuff JB , Rigalleau V

Introduction: End-Stage Renal Disease is a common cause of undernutrition, with a high risk of morbidity and mortality in dialysis. To improve nutritional status before dialysis, we followed up 35 non-dialysed uremic diabetic patients in a prospective and cooperative study.Methods: We analysed glomerular filtration rate (GFR, using 51Cr-EDTA), glycemic control (HbA1c), and nutritional status: body composition (lean body mass, LBM, by DEXA), serum albumin...

ea0011p456 | Endocrine tumours and neoplasia | ECE2006

Prognostic value of KI-67 expression in the cytologic identification of pancreatic endocrine tumors: preliminary data

Manzoni MF , Franchi GM , Piani C , Cappelletti C , Arcidiacono PG , Albarello L , Doglioni C , Bosi E

Background: Organ infiltration and metastasis are the only parameters defining malignancy of pancreatic endocrine tumors. Several studies had demonstrated the prognostic value of Ki-67 expression measured on histological sections obtained from the removed pancreatic endocrine tumors. We postulate that Ki-67 expression measured on fine needle aspiration cytology provides pre-operative indications of the malignancy of pancreatic endocrine tumors.Aim: Aims ...

ea0011p776 | Thyroid | ECE2006

Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to low-dose radioiodine therapy in out-patients with large non-toxic multinodular goitre

Giusti M , Cappi C , Santaniello B , Ceresola E , Augeri C , Lagasio C , Minuto F

Recombinant human TSH (rhTSH) has recently been used as an adjuvant to the treatment of non-toxic multinodular goitre (MNG) by means of 131I. The aim of our study was to evaluate the efficacy of 0.2 mg rhTSH or placebo administered im on 2 consecutive days before a fixed therapeutic dose of 14 mCi of 131I. Thirteen elderly patients (71±7 years) with large non-toxic MNG (group 1) were treated with rhTSH plus 131I. While a control group of 8...

ea0011p912 | Thyroid | ECE2006

Is 131I therapy for hyperthyroidism harmful for testis function?

Ceccarelli C , Canale D , Fiore E , Moschini C , Caglieresi C , Vitti P , Pinchera A

Radioiodine-131 is commonly used for treatment of hyperthyroidism, however the effects on testis function are not known. This prompted us to study testis function in hyperthyroid men after 131I treatment. 15 hyperthyroid patients scheduled for 131I treatment underwent: testis US, hormone assessment and sperm analysis before and 45 days, 3, 6 and 10–15 months after 131I. The control group (for testis volume and semen analysis) was constitut...

ea0009p56 | Growth and development | BES2005

Obese subjects have lower satiety

Giles C , le Roux C , Aylwin S , Hunt C , Ghatei M , Frost G , Bloom S

Background: Obese subjects are usually in a positive energy balance despite their best efforts to lose weight. This study aimed to determine if hunger, nausea and satiety levels differ in lean and obese subjects after consuming varying calorific meals.Method: Following an overnight fast, test meals of 250, 500, 1000, 2000 and 3000 kcal were consumed by 19 lean and 19 obese subjects. Hunger, nausea and satiety levels were measured using visual analogue sc...

ea0007p169 | Neuroendocrinology and behaviour | BES2004

The role of the melanocortin 5 receptor in the hypothalamic regulation of appetite and pituitary function

Sajedi A , Abbott C , Small C , Haskell-Luevano C , Ghatei M , Bloom S

The melanocortin receptors (MCR), MC3R and MC4R, have established roles in feeding and pituitary function. MC5R mRNA expression has been identified at low levels in the hypothalamus. However, a role for this receptor in appetite and pituitary function remains to be elucidated. We investigated the effects of central administration of an MC5R agonist (3,3,3-triphenylpropionyl-His-D-Phe-Arg-Trp-NH2) on food intake and plasma pituitary hormone levels. We did not observe...

ea0083ercp1 | Endocrine-related Cancer | EYES2022

Synchronous eutopic and ectopic papillary thyroid carcinoma

M. L. Guia Lopes , C Saraiva , C Antunes , E Silva , C Limbert , M Chorao , L Viana Fernandes , J Sequeira Duarte

Background: Papillary thyroid carcinomas are the most common thyroid malignancies. They are more prevalent in women and have a bimodal age distribution. Thyroglossal duct cyst carcinomas are extremely rare (occurring in only 1% of all thyroglossal duct cysts). The large majority of these carcinomas are of thyroid origin.Case presentation: A 25-year-old woman with no significant medical history was referred to the Endocrinologist with 1-month complaints o...

ea0067gp25 | Poster Presentations | EYES2019

Atypical presentation of an acromegalic patient

Verdeş Andreea Maria , Căpăţ C , Poiană Cătălina

Background: Acromegaly is a rare disorder, with a prevalence of 6 cases of 100000 and an annual incidence of 3–4 new cases of one million. It is almost always the consequence of GH secreting pituitary adenomas and, rarely, caused by nontumoral somatotrophic hyperplasia.Case presentation: 54 years old patient, heavy smoker, hypertensive, dyslipidemic, obese, presents in June 2019 with unspecific symptoms: physical asthenia, hypersomnia (falls asleep ...

ea0029p99 | Adrenal cortex | ICEECE2012

Cushing’s disease – limitations and boundaries

Idriceanu J. , Preda C. , Galesanu C. , Ungureanu M. , Scripcariu V. , Vasiliu I. , Potorac I. , Popovici R. , Mogos V. , Vulpoi C.

Introduction: Cushing’s disease is the most frequent cause of hypercortisolism. Although the classical form is easy to diagnose, nonspecific features raise differential diagnosis problems. Severe forms are associated with high mortality, but subclinical hypercortisolism also has significant morbidity.Patients and methods: Retrospective study of Cushing’s disease evolution in 14 patients, diagnosed between 2000 and 2011 (11 women, 3 men, age at ...

ea0029p396 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Central diabetes insipidus: about two clinical cases

Nogueira C. , Matos M. , Esteves C. , Jorge G. , Couto J. , Neves C. , Queiros J. , Vinha E. , Bernardes I. , Carvalho D.

Introduction: Central diabetes insipidus (CDI) is produced by the destruction of the magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei which results in decreased arginine vasopressin (AVP) synthesis and secretion.Case report 1: Forty-five year old female, previously healthy, was observed in April 2011 complaining of polydipsia, polyuria, nocturia and weight loss since January. Diabetes mellitus (DM) was excluded and she was ...